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Aim To test the reliability, robustness, and reproducibil-
ity of short tandem repeat (STR) profiling of low template 
DNA (LT-DNA) when employing a defined set of testing 
and interpretation parameters.
Methods DNA from known donors was measured with 
a quantitative real time polymerase chain reaction (PCR) 
assay that consistently detects less than 1 pg/µL of DNA 
within a factor of 0.3. Extracts were amplified in triplicate 
with AmpFSTR® Identifiler® reagents under enhanced PCR 
conditions. Replicates were examined independently and 
alleles confirmed using a consensus approach. Consider-
ing observed stochastic effects inherent to LT-DNA sam-
ples, interpretation protocols were developed and their ac-
curacy verified through examination of over 800 samples.
Results Amplification of 100 pg or less of DNA generat-
ed reproducible results with anticipated stochastic effects. 
Down to 25 pg of DNA, 92% or more of the expected al-
leles were consistently detected while lower amounts 
yielded concordant partial profiles. Although spurious al-
leles were sometimes observed within sample replicates, 
they did not repeat. To account for allelic dropout, inter-
pretation guidelines were made especially stringent for 
determining homozygous alleles. Due to increased het-
erozygote imbalance, stutter filters were set conservatively 
and minor components of mixtures could not be resolved. 
Applying the resultant interpretation protocols, 100% ac-
curate allelic assignments for over 107 non-probative case-
work samples, and subsequently 319 forensic casework 
samples, were generated.
Conclusion Using the protocols and interpretation guide-
lines described here, LT-DNA testing is reliable and robust. 
Implementation of this method, or one that is suitably ver-
ified, in conjunction with an appropriate quality control 
program ensures that LT-DNA testing is suitable for foren-
sic purposes.
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With the increased sensitivity of multiplex polymerase 
chain reaction (PCR)-based short tandem repeat (STR) DNA 
typing kits, low template DNA (LT-DNA) samples, such as 
those from sloughed skin cells deposited on touched ob-
jects, have become a viable source of DNA profiles for fo-
rensic casework. This application of LT-DNA testing has 
been illustrated in many publications (1-6). The poor suc-
cess rate inherent to LT-DNA typing (4) may be improved 
with some modifications to routine protocols, such as add-
ing PCR cycles (6-11). For example, Findlay et al (12), by al-
tering the PCR conditions, was able to obtain a useful, ac-
curate genetic profile from an isolated single cell sampled 
from a buccal swab.
With the opposite goal, aiming to avoid detecting small 
quantities of DNA, the manufacturer of the AmpFSTR® 
Identifiler® (ID) kit (Applied Biosystems, Foster City, CA, 
USA) selected their recommended cycle number, 28, fol-
lowing testing of 27 to 31 cycles (13). Thus, our efforts to 
heighten sensitivity, termed High Sensitivity Testing, in-
cluded raising the cycle number, with 31 being optimal, 
reducing the reaction volume, and doubling the anneal-
ing time. The injection times and voltage were also altered 
for capillary electrophoresis (14). In addition, others have 
shown that purification of the PCR product (15,16), nested 
PCR (17), and whole genome amplification (18) enhance 
sensitivity.
Intensifying the DNA signal through such measures carries 
an increased risk of detecting contamination. Stochastic 
amplification also results in allelic dropout, increased het-
erozygote imbalance, and elevated stutter peaks (7-11,14-
16,19). An allele from exogenous DNA or stutter may be 
perceived as a true allele; conversely, the absence of an al-
lele due to dropout, may lead to a locus incorrectly inter-
preted as homozygous when it is actually heterozygous. 
Moreover, mixtures may be incorrectly resolved due to 
peak imbalance. In order to mitigate these risks, interpreta-
tion guidelines must be adapted and caution applied (20).
Efforts to minimize the occurrence of exogenous DNA in 
samples include specific quality control procedures de-
signed to prevent laboratory based contamination (21,22), 
treatment of consumables to remove DNA (23,24), and the 
selection of reagents shown to be as free of exogenous 
DNA as possible. For example, during the manufacturer’s 
validation of the ID kit no non-specific peaks were gener-
ated (13). To reduce the possibility of including spurious 
alleles in profiles when detected and to facilitate com-
plex data interpretation, samples should be amplified at 
least twice and only alleles that repeat assigned to the 
consensus profile, also termed the composite profile (7-
11,14,16,19). In Gill’s study of 1225 comparisons of 50 am-
plifications examined in pairs, only four samples (0.3%) pro-
duced the same spurious allele twice (7).
Replication of each sample dictates the use of a PCR STR 
system that simultaneously amplifies all of the loci required 
for comparison to a database system. This conserves the 
sample by avoiding dilution of the DNA extract which oc-
curs if 2 kits targeting fewer loci were used. When utilizing 
the ID kit with our optimized parameters, stochastic effects 
were noted for samples amplified with less than 100 pg in 
our study. Over 800 samples were examined to derive in-
terpretation protocols that would account for the stochas-
tic effects observed and, when followed, would generate 
100% correct allelic assignments.
Following review of our validation studies for LT-DNA test-
ing, our quality control, testing, and interpretation pro-
tocols were approved by the DNA Subcommittee of the 
New York State Forensic Science Commission, and subse-
quently, by the entire commission, in December 2005. In 
addition, these studies have since been reviewed and ap-
proved by Federal Bureau of Investigation-trained DNA au-
ditors during routine external audits. The validation studies 
demonstrate that by employing these protocols, LT-DNA 
testing is reliable and robust.
MaTERialS and METHodS
Personnel, workspace, equipment, and consumables’ 
preparation
Laboratory personnel donning double gloves, hair cover-
ings, face masks, booties, eye protection, and laboratory 
coats worked exclusively in rooms dedicated to LT-DNA 
evidence examination or pre-amplification testing. Hoods 
were specifically allocated for each procedure (22). Gloves 
were changed between examination of individual items, 
between assays, and often several times during prepara-
tion of an assay. Workbenches, tools, and instruments were 
cleaned with 10% bleach followed by water and 70% eth-
anol before and after each procedure and between each 
item of evidence examined. A thorough weekly cleaning 
of the entire laboratory space and equipment was per-
formed.
All consumables and water were irradiated in a 
Stratalinker® UV Crosslinker 2400 (Stratagene, La Jolla, 
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CA, USA) prior to use (23). The strength of the UV light in the 
Stratalinker was tested weekly (25). Pipets were calibrated 
biannually and only aerosol-resistant filter tips were used. 
For manual processes, only 1 sample tube was opened at 
a time and either a clean cap opener or paper tissue was 
used. Tissue culture technique was employed in order to 
avoid crossing over an open tube or plate (21). To ensure 
that the sensitivity of the capillary electrophoresis (CE) ma-
chines was maintained, the heights of the 200 bp internal 
GeneScan® 500 LIZ® Size Standard (Applied Biosystems) in-
jected with each amplification negative were monitored. 
Prior to using each electrophoresis capillary with samples, 
GeneScan® 500 LIZ® Size Standard was injected to confirm 
that the capillaries were free of exogenous DNA and func-
tioning.
Moreover, analysts completed additional training and 
competency testing for the described procedures, and pe-
riodically performed LT-DNA testing on proficiency tests. 
For proficiency test purposes, if high amounts of DNA were 
recovered, extracts were diluted and the target amount of 
LT-DNA, 100 pg, processed.
Quality control of reagents
All reagents used in evidence examination, extraction, 
quantitation, amplification, and separation were tested 
with their respective assay to ensure they were function-
ing and free of contaminating DNA. The sensitivity of the 
ID kit was verified for each new kit or every 4 months with 
amplification of 100 pg, 25 pg, and 6.25 pg of DNA. The 
number of alleles determined for each concentration of 
DNA was compared with the expected results described 
in this study. If the anticipated results were not generated 
with a certain kit, it was not used.
Samples
Several sample sources were used in these studies. These 
included control DNA as indicated, buccal swabs and se-
men swabs from known donors, previously processed 
blood stored on stain cards, human bones, and items han-
dled by known individuals. The DNA profiles of all of these 
sources were previously determined; thus, the profiles 
generated from this study could be compared and veri-
fied. Negative controls which consisted of irradiated (23) 
UltraPure DNase/RNase-Free Distilled Water (GIBCO Invi-
trogen, Carlsbad, CA, USA) were processed in the same 
or a more sensitive manner than their corresponding 
samples.
Recovery of dna from touched evidence
Samples were swabbed with the New York City Office of 
Chief Medical Examiner’s swab (patent pending) pre-moist-
ened with 0.01% sodium dodecyl sulfate (SDS). Swabbing 
was performed with a light touch and, if applicable, with 
the grain of the item. If needed, more than one swab per 
item or section of an item was used. DNA was extracted 
from swabs within 1-2 days of collection.
Extraction
Samples were incubated in 0.01% SDS and 0.72 mg/mL 
proteinase K at 56°C for 30 minutes with shaking at 1400 
rpm, then at 99°C for 10 minutes without shaking. Follow-
ing centrifugation, the digest was purified and concentrat-
ed with a Microcon® 100 (Millipore, Billerica, MA, USA) pre-
treated with 1 ng of poly-A RNA and eluted with 20 µL of 
water (26). Extracts were quantitated and amplified within 
1-3 days of extraction. Some samples were extracted using 
Chelex resin (Bio-Rad, Hercules, CA, USA) (27).
Quantitation
Two microliters of sample were quantitated on the Rotor-
Gene Q 3000® (Qiagen, Valencia, CA, USA) using an Alu-
based real time PCR assay based on the method described 
by Nicklas and Buel (28), with the exception of the addi-
tion of 0.3 µL of 100X SYBR green I (Molecular Probes) and 
0.525 mg/mL BSA in a 25 µL reaction volume. The concen-
trations of 2 known sources of human genomic DNA (Pro-
mega Corporation, Madison, WI, USA) used for the stan-
dards and calibrators were verified in triplicate 3 times for a 
total of 9 tests using a Synergy HT Multi-Mode Microplate 
Reader (BioTeq Instruments, Winooski, VT, USA). The hu-
man genomic DNA was stored at -20°C in single use ali-
quots. The dynamic range of the assay extends from 0.39 
pg/μL to 1600 pg/µL and measurements are within 30% 
of their expected value. The no template control threshold 
was set at 0.1 pg/µL. In addition, for concordance studies 
for this quantitation assay, samples were measured with 
the Quantiblot slot-blot method (Applied Biosystems) ac-
cording to the manufacturer’s protocol.
amplification
Samples as indicated and negative controls were amplified 
in triplicate using the AmpFSTR® Identifiler PCR Amplifica-
tion Kit according to the manufacturer’s recommendations 
with the exception of a 2-minute annealing time and a 
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half-reaction volume with 2.5 U of TAQ for 31 cycles (14). All 
amplifications were carried out in the AB GeneAmp® PCR 
System 9700 thermal cycler (Applied Biosystems) within 
thin-walled 0.2 mL AB MicroAmp® (Applied Biosystems). 
AmpFSTR® Control DNA 9947A (Applied Biosystems) was 
amplified with the target amount, 100 pg of DNA.
Separation
Five or 6 μL of each PCR product and 0.375 µL of Gene-
Scan® 500 LIZ® Size Standard (Applied Biosystems) were 
prepared with HIDI formamide (Applied Biosystems) for a 
total volume of 50 µL and injected at either 1 kV for 22 sec-
onds (low), 3 kV for 20 seconds (normal), or 6 kV for 30 sec-
onds (high) on the ABI Prism® 3100 Genetic Analyzer (Ap-
plied Biosystems). All 150 pg, 100 pg, and 75 pg samples 
were injected low; 50 pg, 25 pg, and 20 pg samples were 
injected normal; and 12.5 pg and 6.25 pg samples were in-
jected high, unless otherwise indicated. For the low and the 
normal injections, 0.5 µL of allelic ladder and 1 µL of a 1/10 
dilution of the 9947A positive control with 0.375 µL of LIZ 
were prepared with HIDI formamide in a total volume of 16 
µL. For the high injection, 0.3 µL of allelic ladder and 1 µL of 
a 1/20 dilution of 9947A positive control were prepared in 
the same fashion. Data were collected using non-variable 
binning. In addition to injecting each sample replicate, as 
indicated, 5 µL of each of the 3 replicate PCR products were 
combined and mixed to form a pooled sample. Five micro-
liters of this pooled sample was also injected.
analysis
Data were analyzed with GeneScan® and Genotyper® 
Analysis software (Applied Biosystems) with a peak height 
threshold of 75 relative fluorescence units (RFU), a 251-
baseline window, and a general filter of 10%. This filter 
removes labels from peaks that are less than 10% of the 
height of the highest peak at each locus. Stutter filters 
provided by the manufacturer were as follows: 6% (TPOX 
and THO1), 9% (D7S820 and CSF1PO), 10% (D13S317 and 
D5S818), 11% (D3S1358, vWA, and FGA), 12% (D8S1179), 
13% (D21S11 and D16S539), 15% (D2S1338), 16% (D18S51), 
and 17% (D19S433). For single-source samples, stutter 
peaks were also removed if they were less than 20% of 
the height of the main peak. The consensus profile, also 
termed the composite profile, was generated including all 
alleles that were labeled in at least 2 of the 3 replicates.
Results were expressed as the percentage of alleles deter-
mined compared with the expected 32 alleles or the num-
ber of complete database loci determined. The locations 
searched in the US database include all those typed in the 
ID kit with the exception of D19S433, D2S1338, and Am-
elogenin. Loci were considered to be complete and not 
partial when they contained a heterozygote pair or a true 
homozygote allele. For samples amplified with less than 20 
pg of DNA, when only 1 peak was observed at a locus, that 
locus was always considered a potential false homozygote. 
The designation “Z” was used to indicate the possible pres-
ence of a second allele.
Results were also expressed as peak height ratios (PHR), 
defined as the smaller peak/larger peak, with perfect bal-
ance resulting in a peak height ratio of 1. Furthermore, 
stutter rates were calculated as follows: (number of alleles 
observed in the stutter position/number of true alleles de-
tected) × 100. Unless otherwise indicated, when evaluating 
stutter, samples were analyzed without the application of 
the loci specific stutter filters or the 10% general filter. In or-
der to avoid miscalculating ratios for both intralocus peak 
balance and stutter, only loci with alleles below the CE in-
strument’s saturation threshold were considered.
RESulTS
Quantitation
The quantitative real time PCR assay used in our LT-DNA 
studies proved to be accurate and reliable. Over 5 assays, 
measurements of 28 samples of 50 pg/µL of standard DNA 
varied by a factor of 0.3 or less from the expected value. 
The standards included 9947A control DNA, Quantiblot 
standard A, and 2 sources of genomic DNA from Promega 
whose concentrations were verified previously with a spec-
trophotometer in triplicate 3 times for a total of 9 tests.
To determine the range of this precision, a buccal swab 
sample, previously measured in triplicate 3 times, was di-
luted by factors of 2 from 1000 pg/µL to 0.12 pg/µL and 
these concentrations were quantitated in triplicate. Mea-
sured values for the 1000 pg/µL, 500 pg/µL, and 250 pg/µL 
samples were within 33%, 36%, and 30% of their respective 
values. With less DNA input, measurements were more ac-
curate, varying 21% and 11% from their expected values 
for the 125 pg/µL and 62.5 pg/µL samples, respectively. 
Considering that at most 5 µL of template volume may 
be added to our amplification reaction, the concentra-
tions of DNA surrounding the range of LT-DNA testing, 
31.25 pg/µL to 0.98 pg/µL, were also precise, measur-
ing within 12 ± 5% of their expected values (Figure 
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1). This precision extended down to 0.24 pg/µL with a vari-
ance of 12%. However, the average measured value for 
0.12 pg/µL was slightly more variable, within 45% of the 
expected amount.
Furthermore, the reproducibility of the test was con-
firmed with 15 buccal samples measured in triplicate 3 
times which varied at most 9.8% within an experiment and 
11.17% between experiments (data not shown). Additional 
measurements were made of 15 blood and 15 semen sam-
ples in duplicate. Five of each of these samples were ampli-
fied with the same template amount and yielded compa-
rable peak heights (data not shown).
initial design
The duplicate and the triplicate amplification approaches 
were compared using 37.5 pg of template DNA distributed 
over 2 or 3 amplifications (data not shown). Using 3 am-
plifications, despite the lower amount of DNA amplified 
in each reaction, resulted in more confirmed alleles (29). 
Furthermore, in 33% of 24 buccal samples amplified with 
either 25 pg, 12.5 pg, or 6.25 pg, each peak of a hetero-
zygote pair was observed as a single peak in 2 amplifica-
tions, while in the third amplification, both peaks were 
present. Employing the consensus approach with 3 rep-
licates, rather than 2, would confirm both alleles. With 
both methodologies, however, spurious alleles were 
resolved. As demonstrated in the experiments below, the 
triplicate approach provides additional information that 
can be used for mixture and homozygote assessment. For 
example, in 17% of the 24 samples referred to above, the 
same single peak of a heterozygote pair was apparent in 2 
amplifications whereas a third amplification revealed the 
other peak.
Reproducibility and precision for amplification and 
separation
In order to determine the precision and reproducibility of 
multiple injections of the allelic ladder, 16 preparations of 
allelic ladders were injected twice on the same day on 2 
different instruments at 1 kV 22 seconds (low), 3 kV 20 sec-
onds (normal), and 6 kV 30 seconds (high) parameters. The 
standard deviation of the average base pair size of the larg-
est and the smallest alleles at each locus was on average 
between 0.04 and 0.07 bp for all conditions. Additionally, 
data collected for 24 ladders injected at high parameters 
on different days and instruments exhibited, on average, a 
variation of 0.47 bp. Yet, within an injection or between 2 
injections performed on the same day, the precision was 
within 0.07 bp as above. For each study, all alleles were as-
signed correctly (data not shown).
The reproducibility of the modified PCR conditions was 
verified with amplifications of 9947A control DNA, as well 
as non-probative DNA extracts. Over a period of 4 months, 
24 separate amplification products of 100 pg of 9947A 
control DNA injected with high, normal, and low injec-
tion parameters were evaluated. All samples generated 
the correct allelic determinations with no instances of al-
lelic drop-in or dropout. Within each injection condition, 
the peak heights of alleles for each locus were comparable 
(data not shown).
Furthermore, 9947A control DNA and 5 different buccal 
sample extracts were amplified in triplicate on different 
days using 100 pg, 75 pg, 50 pg, 25 pg, 12.5 pg, and 6.25 
pg of DNA. All 108 PCR products were injected on 2 differ-
ent instruments at 3 kV for 20 seconds (data not shown). All 
samples generated the correct allelic determinations. Since 
the single-source 100 pg and 75 pg samples displayed sat-
urated loci at this injection parameter, they were also in-
jected with 1 kV and 22 seconds. Conversely, peaks below 
threshold were apparent with 12.5 pg and 6.25 pg sam-
ples, and thus they were injected with 6 kV and 30 seconds, 
resulting in at least a 2-fold increase in peak heights and 
one more called locus. This CE strategy of using different 
Figure 1.
Sensitivity of the quantitative real time polymerase chain reaction assay 
within the low template dna range. a buccal swab previously measured 
in triplicate 3 times was diluted from 1000 pg/µl to 0.12 pg/µl, as indi-
cated. Results are depicted for samples diluted from 31.25 pg/µl to 0.98 
pg/µl. data for 1000 pg/µl to 62.5 pg/µl and 0.49 pg/µl to 0.12 pg/µl 
are not shown. Results are expressed as the mean ± standard deviation, 
where n = 3. The average value for each measured amount of dna is la-
beled.
255Caragine et al: Low Template Testing and Interpretation
www.cmj.hr
injection parameters based upon starting DNA amounts 
was adopted for all subsequent validation experiments.
Figure 2 illustrates the average number, over all replicates, 
of complete loci which are defined as either a heterozy-
gote pair or a true homozygote. For all concentrations and 
samples, the amplification success for the replicates was 
consistent, as the average standard deviation for the num-
ber of loci detected was 1.03 loci on one instrument and 
1.02 loci on another instrument. Larger amounts of tem-
plate DNA produced smaller variances. Amplification of 
12.5 pg and 6.25 pg of DNA had to be treated as potential-
ly false homozygotes; therefore, fewer loci were deemed 
complete.
Sensitivity and allelic dropout
Amplification of LT-DNA samples typically produces sto-
chastic phenomena such as allelic dropout and drop-in, 
intralocus peak imbalance, and increased stutter. For the 
following studies, these effects were evident with 100 pg 
of DNA or less and were magnified with amounts below 
50 pg. 9947A control DNA samples and 5 buccal samples 
were amplified in triplicate with starting quantities of 100 
pg, 75 pg, 50 pg, 25 pg, 20 pg, 12.5 pg, and 6.25 pg and 
were injected on 2 different instruments. Control sample 
9947A was also amplified at 150 pg, but not at 20 pg. At 
least 92% of the expected alleles were determined in the 
composite or consensus profile for all samples amplified 
with 25 pg or more. Amplification of 12.5 pg and 6.25 pg 
generated 77% and 51% of the expected alleles, respec-
tively (Figure 3). Most importantly, correct alleles were as-
signed for all samples at all loci.
Although allelic dropout occurred with smaller amounts of 
DNA, injecting these samples with high parameters yield-
ed robust peak heights, often above 1000 RFUs (Figure 
4). Since less sensitive injection conditions were required 
for greater amounts of DNA injected, peak heights with-
in some loci did not vary significantly among concentra-
tions. For example, peak heights for 75 pg samples were 
only 2% taller than those of 12.5 pg samples, although 
for single cell amounts, 6.25 pg, the difference was 30%. 
What was more striking to note was that for all concen-
trations, the peak heights of alleles at some loci, such as 
THO1, D16S539, and D2S1338, were considerably shorter 
than alleles labeled with the same color at other loci. It fol-
lows that different loci displayed varying degrees of allelic 
dropout. For the 25 pg samples, the larger loci, CSF1PO, 
D2S1338, D18S51, and FGA did not display either one 
or both alleles in 28% of the amplification replicates. 
Figure 2.
Reproducibility of single amplifications with enhanced polymerase 
chain reaction conditions. Five different buccal extracts and 9947a con-
trol dna were amplified in triplicate over a range of concentrations from 
100 pg to 6.25 pg on different days. individual replicates were evaluated 
for the number of complete loci defined as a heterozygote pair or a true 
homozygote. For samples with less than 20 pg of dna, loci with single al-
leles are considered false homozygotes and are not complete. Results are 
expressed as the average ± standard deviation of the population, where 
n = 3 for a total of 108 amplifications. Results for 9947a control dna are 
represented by the diagonally striped columns and the 5 buccal extracts 
by the dotted, open, hashed, lined, and closed columns.
Figure 3.
Percentage of alleles determined in the composite profile. 9947a control 
dna and 5 different buccal sample extracts were amplified in triplicate 
at varying concentrations from 150 pg to 6.25 pg of dna on different 
days. The number of alleles that repeated in 2 of the 3 replicate amplifi-
cations of each sample was compared with the total expected number 
of alleles, 32. data are expressed as the average percentage ± standard 
deviation of the population, where n = 6 confirmed samples for 100 pg, 
75 pg, 50 pg, 25 pg, 12.5 pg, and 6.25 pg; n = 2 for 20 pg; and n = 1 for 150 
pg for a total of 117 amplifications.
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Two loci, THO1 and D16S539, also showed high degrees of 
allelic dropout, 26.6% and 33.3%, respectively, regardless 
of their position as compared with 9.6% for the remaining 
loci. Regarding only the dropout rate for the second allele 
of a heterozygous pair, this was 2.2 times higher for THO1, 
D16S539, and the largest loci than for the others. These 
sensitivity titrations were used to formulate interpretation 
protocols ensuring proper recognition of allelic dropout 
and minimizing the risk of calling a false homozygote.
Stochastic effects, spurious alleles, and stutter
Using the results of the sample amplifications described 
above, heterozygote peak imbalance was examined. One 
representative data set, shown in Figure 5, depicts 9947A 
control DNA amplified in triplicate from 150 pg to 6.25 pg 
and separated consecutively on 2 different CE instruments. 
Amplification of 100 to 150 pg of DNA did not demon-
strate significant peak imbalance as PHRs were on average 
within 77 ± 18%. Specifically, the PHRs for 150 pg peaks 
were 70% to 99%. One hundred picogram samples exhib-
ited slightly more imbalance as the PHRs extended from 
23% to 98%. Heterozygote pairs of 50 pg to 6.25 pg of DNA 
varied more, on average 62 ± 22%. Although the average 
imbalance for template amounts of 50 pg, 25 pg, 12.5 pg, 
and 6.25 pg was relatively similar – 66%, 60%, 57%, and 
59%, respectively, the peaks varied more for the low-
er DNA inputs. The range of imbalance observed was from 
7.5% to 98%. These PHRs were consistent between the 2 
CE instruments. In summary, it was found that no sample 
amplified with more than 20 pg, where the second peak 
was less than 30% of the main peak, was actually a het-
erozygote. Although peak height ratios varied widely, the 
average value, including the standard deviation, was not 
below 30% (Figure 5). Only for samples amplified with less 
than 20 pg, was a true heterozygous peak observed to be 
less than 30% of the main peak, and this occurred infre-
quently with a rate of 8%.
Another concern arising from enhanced amplification pro-
tocols is the detection of extraneous sources of DNA. Data 
from 12 extraction negative controls and 10 amplification 
negative controls that had been amplified in duplicate or 
triplicate for a total of 57 replicates and were injected at 
various parameters, were examined for spurious alleles. 
Drop-ins occurred in 8% of the amplification negatives and 
11% extraction negatives. However, implementation of the 
consensus approach addressed this concern as no alleles 
repeated. Regarding these non-repeating spurious alleles, 
the average number per replicate for all 57 amplifications 
was 0.7 ± 0.28. The average number of drop-ins over all 3 
replicates for 22 controls was 0.9 ± 1.4. Considering only 
the 11 control samples that displayed drop-ins, the aver-
age number over all replicates was 1.8 ± 1.6.
For samples containing DNA, spurious alleles were de-
tected at similar rates if peaks in the -4 stutter position 
Figure 4.
locus to locus peak height comparisons. data were evaluated from 3 
separate buccal samples amplified in triplicate on different days from 
100 pg to 6.25 pg, as indicated. Values are expressed as the average peak 
height of heterozygote alleles for each locus + standard deviation, where 
n = 9. Quantities amplified are represented as follows: 100 pg (solid), 75 
pg (diagonal), 50 pg (open), 25 pg (horizontal stripes), 12.5 pg (vertical 
stripes), and 6.25 pg (dots). letters in parenthesis represent dye colors. 
only heterozygous loci were included.
Figure 5.
Peak imbalance within heterozygote loci. 9947a control dna ampli-
fied in triplicate with 150-6.25 pg of dna, as indicated, was injected 
consecutively onto 2 capillary electrophoresis (CE) instruments, CE 1 
(closed circles) and CE 2 (closed squares). The average peak height ra-
tio (PHR)±standard deviation, expressed as a percentage, was calculated 
for each concentration, where n = 30 loci for 150 pg, 100 pg, and 25 pg; 
n = 29 loci for 50 pg; n = 19 loci for 12.5 pg: and n = 8 loci for 6.25 pg.
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were considered separately. The data set from the sensi-
tivity study of 6 different samples amplified in triplicate 
at a range of concentrations from 100 pg to 6.25 pg for a 
total of 38 samples and 114 amplifications was examined. 
A foreign allele was detected in 28% of these amplifica-
tions. The majority of these peaks were in the -4 stutter 
position, totaling 18.4% of the replicates. The remaining 
foreign alleles, 9.6% of the total amplifications, were either 
in the +4 stutter position (6.1%) or in neither of these posi-
tions (3.5%).
Amplification of LT-DNA with additional cycles generat-
ed increased stutter. Using the same PCR conditions with 
the exception of the cycle number, the rate of stutter was 
compared between the 28-cycle high template DNA (HT-
DNA) system and the 31-cycle LT-DNA system. Samples 
were analyzed without the locus-specific stutter filters or 
the general 10% filter. As shown in Table 1 and described 
by other authors (7), the occurrence of stutter increases for 
low amounts of DNA. Using our system, an increase of a 
factor of 2 was observed. However, the average height of 
the stutter peak relative to the main peak did not differ sig-
nificantly. For example, only 3% of the LT-DNA stutter peaks 
observed were above 20%.
Figures 6 and 7 depict the average and standard deviations 
of stutter percentages, as well as the maximum and mini-
mum stutter values, for each locus for 2 quantitative cat-
egories of low template DNA. Although stutter averages 
do not vary between the amounts of DNA amplified, the 
range and the highest percentage of stutter were larger for 
some loci amplified below 50 pg. The tallest stutter peak 
for some loci, such as D3, could be artificially inflated by 
a dye artifact at that position which could contribute to 
the height. Nevertheless, these peaks should be noted as 
they would not be filtered by the software. Plus 4 stutter 
was rare, but was observed particularly with the 100 pg 
samples. Not considering the observed stutter, but rather 
all loci that could potentially stutter, the frequency of stut-
ter approaches that observed with 28-cycle amplification 
of 100 pg of DNA (15). Specifically, 3.1% of the potential 
stutter events in samples amplified with 100 pg exceeded 
either the software cut-off values or the 10% general filter, 
the only filters applied to mixed samples. For the samples 
amplified from 50 pg or less, this value increased to 5.4%. 
These values varied by 1% if only the locus specific fil-
ters were applied.






no (%) of observed 
stutter peaks




28 cycles: 500 pg 30  845 238 (28.2)  0 (0.0) 0 (0.0)
31 cycles: 100 pg 61 1 664 974 (58.5) 53 (5.4) 8 (0.8)
31 cycles: 20, 25, and 50 pg 24   586 300 (51.2) 32 (10.7) 9 (3.0)
*data sets amplified with 500 pg for 28 cycles, 100 pg for 31 cycles, and 20 pg, 25 pg, or 50 pg with 31 cycles were examined for the presence of 
peaks in the stutter position. The rates of stutter were expressed as percentages and defined as follows: the percentage of alleles with stutter 
(the number of observed stutter peaks/the total number of true alleles detected over all loci) × 100, the percentage of stutter peaks not removed 
(number of stutter peaks above the locus specific filter thresholds and the 10% general filter/number of observed stutter peaks) × 100, and the 
percentage of stutter ≥20% (number of stutter peaks that were above or equal to 20% of the height of the main peak/number of observed stutter 
peaks) × 100.
Figure 6.
locus-specific stutter percentages for 100 pg samples. Sixty one ampli-
fications of 100 pg with identifiler® for 31 cycles were analyzed without 
application of the locus-specific stutter filters or the 10% general filter. 
The following loci were examined: d8S1179 (n = 103), d21S11 (n = 93), 
d7S820 (n = 45), CSF1Po (n = 34), d3S1358 (n = 94), THo1 (n = 30), 
d13S316 (n = 93), d16S539 (n = 67), d2S1338 (n = 62), d19S433 (n = 81), 
vWa (n = 77), TPoX (n = 11), d18S51 (n = 69), d5S818 (n = 73), and FGa 
(n = 42). Results are expressed as the average percentage stutter rep-
resented by a closed square ± standard deviation. Maximum and mini-
mum percentage stutter values were also designated by closed triangles 
and closed diamonds, respectively. asterisk indicates that the maximum 
stutter value observed at d18S51 (60%) was outside the range of the 
graph.
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Evaluation of identifiler® using the niST SRM dna Panel 
and non-probative case work samples
Ten samples from the National Institute of Standards and 
Technology standard reference material (NIST SRM) DNA 
Panel and 68 non-probative case work samples (15 buc-
cal samples, 15 blood samples, 15 semen samples, and 
23 bone samples) were amplified repeatedly and inject-
ed on 2 different instruments at the appropriate parame-
ters. Initially, 1 allele at vWA was missing in one NIST stan-
dard sample. Accordingly, the sample was re-injected 
with high parameters and the allele was detected (this 
allele was also confirmed by re-amplification). The op-
timum amount of DNA, 100 pg, was amplified with the 
exception of 6 bone samples for which the amount of 
template DNA available for each amplification replicate 
was 10 pg, 20 pg, 25 pg, 30 pg, 40 pg, or 80 pg. On aver-
age, the composite profiles revealed that full profiles or 
100% of the database loci were generated for the NIST, 
buccal, and semen samples. For the blood and the bone 
samples, 99.16% and 99.4% of the loci, respectively, were 
determined. No drop-in alleles were apparent in the com-
posite profiles. Moreover, peak heights for each color, in-
jection parameter, and instrument were consistent. Fur-
thermore, 109 non-probative casework samples from 
touched or handled items or single fingerprints were also 
examined (30). At least 40 pg of DNA was recovered from 
42% of these samples, with four containing sufficient 
DNA for HT-DNA testing. Thirty nine of the remaining 
samples were amplified with at least 10 pg of DNA in trip-
licate. There were 61.5% of the LT-DNA samples amplified 
which yielded database eligible profiles, of which 48.7% 
were single source and 12.8% were major contributors to 
mixtures (Table 2).
All consensus profile results from amplifications with 
known samples and 9947A control DNA described in this 
paper demonstrate concordance with the results from am-
plification of high template amounts of DNA of these same 
samples with standard protocols. Following validation ap-
proval, consensus profiles from forensic casework were also 
examined and were similarly deemed concordant if pro-
files from LT-DNA samples amplified with enhanced con-
ditions were consistent with profiles from other HT-DNA 
samples in the case amplified with standard protocols. All 
sample comparisons (n = 319) were concordant.
Figure 7.
locus-specific stutter percentages for 50 pg, 25 pg, and 20 pg samples. 
Twenty-four amplifications of 50 pg, 25 pg, and 20 pg with identifiler® 
for 31 cycles were analyzed without application of the locus-specific 
stutter filters or the 10% general filter. The following loci were exami-
ned: d8S1179 (n = 37), d21S11 (n = 27), d7S820 (n = 13), CSF1Po (n = 19), 
d3S1358 (n = 32), THo1 (n = 10), d13S316 (n = 16), d16S539 (n = 25), 
d2S1338 (n = 18), d19S433 (n = 26), vWa (n = 21), TPoX (n = 6), d18S51 
(n = 20), d5S818 (n = 18), and FGa (n = 12). Results are expressed as the 
average percentage stutter represented by a closed square ± standard 
deviation. Maximum and minimum percentage stutter values were also 
designated by closed triangles and closed diamonds, respectively. as-
terisk indicates that the maximum stutter values observed at d7S820 
(40%), d3S1358 (49%), and d16S539 (39%) were outside the range of 
the graph.
Table 2. Profiles generated from dna recovered from touched items*
Sample group
no (%) of samples 
amplified
no (%) of database eligible 
samples in each group
no (%) of database eligible 
samples of total amplified (n = 39)
10 pg – 19 pg – single source  9 (23.1)  2 (22.2)  2 (5.1)
10 pg – 19 pg – non-deducible mixtures  1 (2.6)   N/A   N/A
20 pg – 100 pg – single source 18 (46.1) 17 (94.4) 17 (43.6)
20 pg – 100 pg – deducible mixtures  7 (17.9)  5 (71.4)  5 (12.8)
20 pg – 100 pg – non-deducible mixtures 4 (10.3)   N/A   N/A
Total 39 (100.0)   N/A 24 (61.5)
*dna in the low template dna range was recovered from 39 samples from touched or handled items or single fingerprints. Sample groups were 
defined according to the amount of dna amplified in each of 3 replicates and whether the resulting profiles were from 1 source or were mixtures 
wherein the major component could or could not be resolved. data are expressed as the number or percentage of either samples amplified or 
database eligible profiles which contain at least 6 complete loci and 10 loci overall.
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Mixture studies
Four studies were performed to examine the behavior of 
contributors to LT-DNA mixtures. Dropout rates for a cer-
tain concentration of each contributor were higher than 
for the same concentration of DNA in a single-source sam-
ple. Mixtures were resolved according to the interpreta-
tion protocols developed from this study as described in 
the discussion section of this paper. Examination of the 
pooled sample revealed that the peak height ratios of het-
erozygote pairs were 25% more balanced than those of 
individual replicates for 25 pg samples. Accordingly, the 
pooled sample results better approximated the known 
mixture ratios, and thus were used to confirm allelic as-
signments. Moreover, if there appeared to be inconsisten-
cies between the replicates and the pooled sample did 
not confirm the calls from the individual replicates, the 
locus was deemed inconclusive. However, the pooled 
samples were never used independently as an interpre-
tation tool, as they sometimes contained alleles that did 
not repeat and thus a drop-in allele could potentially be 
assigned.
The first mixture study consisted of one series of Chelex 
100 extracted samples mixed in ratios of 5:1, 3:1, and 1:1 
with 100 pg, 50 pg, and 25 pg of total DNA. The second 
series of mixtures contained 100 pg of DNA mixed at 50:1, 
20:1, 10:1, 5:1, 3:1, 1:1, 1:3, 1:5, 1:10, 1:20, and 1:50 ratios. 
For the third and forth series, samples extracted with the 
high sensitivity method were mixed at 49:1, 19:1, 9:1, 4:1, 
2:1, 1:1, 1:2, 1:4, 1:9, 1:19, and 1:49 ratios with 100 pg of 
DNA. For all studies, mixtures were amplified in triplicate. 
Table 3 illustrates the number of complete and partial loci 
that were assigned to the major components of 100 pg 
mixtures from all of the series. At least 10 complete loci 
were deduced from mixtures with ratios from 1:50 to 1:4. 
Mixtures with the 1:3 and 1:2 ratios were partially resolved, 
with on average 3.7 complete and 6.4 partial loci. The 50 
pg mixtures generated 11 and 8 complete loci from 1:5 
and 1:3 mixtures, respectively. Although the 25 pg 1:5 and 
1:3 mixtures yielded on average only 4 or 3 complete loci, 
10 or 9 partial loci were deduced, respectively (data not 
shown).
All of these deductions were correct; however, the mi-
nor components could not be reliably deduced. Rather, 
peaks attributable to the minor component were appar-
ent and some repeated for all concentrations and ratios 
tested. For example, the median number of repeating mi-
nor peaks detected in 100 pg mixed samples with 1:50-
1:49, 1:20-1:19, 1:10-1:9, 1:5-1:4, and 1:3-1:2 ratios were 
1, 3, 8, 13, and 13, respectively (Table 4). Similar results 
were observed for 50 pg and 25 pg mixtures, with a me-
dian of 12.5 minor repeating alleles observed (data not 
shown). Additionally, evaluation of all 4 sets of mixtures 
or 126 amplifications showed 176 repeating peaks. Of 
these, all but 2 peaks (1.1%) were either attributable to 
the major or minor components or were in the stut-
ter position.











1:50a 11  2 13 0
1:50b 11  2 13 0
1:49c 12  0 13 0
1:49d 12  1 13 0
1:49e 11  2 13 0
1:49f 10  3 13 0
1:20a 11  2 13 0
1:20b 11  2 13 0
1:19c 10  3 13 0
1:19d 12  1 13 0
1:19e 11  2 13 0
1:19f 10  3 13 0
1:10a 10  3 13 0
1:10b 10  3 13 0
1:9c  9  4 13 0
1:9d 12  1 13 0
1:9e 11  2 13 0
1:9f 10  3 13 0
1:5a 10  3 13 0
1:5b  8  5 13 0
1:5g 12  1 13 0
1:4c  5  8 –† 7
1:4d 10  1 13 0
1:4e  6  1  9 4
1:4f  5  8 –† 2
1:3a  5  3 –† 5
1:3b  4  7 –† 5
1:3g  8  5 13 0
1:2c  1  0 –† 9
1:2d  3 10 –† 4
1:2e  3 10 –† 4
1:2f  2 10 –† 9
*100 pg mixtures of 6 buccal samples were prepared in ratios of 1:50 
to 1:1 as indicated (1:1 mixtures not shown). designations of “a,” “b,” 
“c,” “d,” “e,” “f,” and “g” correspond to the combination of samples 
used to prepare the mixtures. all mixture samples were amplified in 
triplicate.
†deduced profiles had fewer than 6 complete loci.




Since the amount of template amplified is directly corre-
lated with STR performance, the reliability of the quantita-
tion system is essential to effectively triage a sample for 
enhanced PCR conditions. Equipped with a quantitative 
assay measuring within 30% of the actual amount of 
DNA, reproducibility studies demonstrated that our 
amplification protocols produce predictable results. How-
ever, based on the fact that our quantitation assay targets 
a 124 bp fragment of DNA, approximating the size of the 
smallest loci amplified with the ID system, amplification 
success for a degraded forensic sample would not be as 
accurately assessed. Additional screening assays to identify 
degraded DNA are warranted in order to better triage sam-
ples for amplification with mini-STRs (31). However, even 
with mini-STRs, the stochastic effects inherent to LT-DNA 
must still be considered.



































1:50a   N/A     N/A  2
1:50b N/A     N/A N/A   2
1:49c N/A    1
1:49d   0
1:49e N/A  N/A  N/A N/A  1
1:49f  N/A  N/A N/A N/A   N/A N/A  0
1:20a      N/A   N/A  5
1:20b    N/A    N/A N/A   3
1:19c     0
1:19d           4
1:19e N/A     N/A  N/A    N/A  3
1:19f N/A N/A N/A  N/A N/A  0
1:10a       N/A     N/A   9
1:10b        N/A     N/A N/A   7
1:9c       1
1:9d               9
1:9e  N/A     N/A   N/A     N/A  8
1:9f       N/A N/A N/A   N/A N/A  8
1:5a        N/A       N/A  13
1:5b        N/A      N/A N/A  13
1:5g    N/A       N/A     13
1:4c               9
1:4d                 14
1:4e  N/A     N/A   N/A      N/A 10
1:4f     N/A N/A  N/A    N/A N/A  8
1:3a        N/A       N/A  14
1:3b        N/A      N/A N/A  13
1:3g    N/A       N/A     13
1:2c                 13
1:2d                 16
1:2e  N/A     N/A   N/A      N/A  9
1:2f       N/A N/A  N/A     N/A N/A 11
*100 pg mixtures of 6 buccal samples were prepared in ratios of 1:50 to 1:1 as indicated (1:1 mixtures not shown). designations of “a,” “b,” “c,” “d,” “e,” 
“f,” and “g” correspond to the combination of samples used to prepare the mixtures. all mixture samples were amplified in triplicate. loci for each 
sample concentration were assigned a closed circle if a minor component allele repeated in 2 of the 3 amplification replicates, or an open circle if a 
minor allele was observed in only one replicate. “n/a” was assigned to loci for which the mixture components shared genotypes.
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Sample interpretation: allelic drop-ins
The first step in analysis is construction of the consensus 
profile, termed the composite profile, which contains only 
alleles that repeat in 2 of the 3 replicates. The advantage of 3 
amplifications rather than 2 is correlated with the locus drop-
out rate and becomes obvious for lower amounts of DNA. If 
the dropout of the starting amount divided by 3 was very 
similar to the dropout rate divided by 2, then the success 
rate would be higher for the triplicate amplification method 
than for the duplicate method. Additional experiments to 
identify the exact threshold are in progress; however, given 
that many forensic touched samples are mixtures, a tripli-
cate approach from the onset may prove most efficient.
Due to the increased sensitivity of the system, as is evi-
denced from our titration studies, drop-in alleles are ex-
pected and may originate from a very minor contributor 
to a sample. From our validation, these drop-in alleles did 
not display any repeated pattern; therefore, no conclusions 
could be drawn regarding the source of these alleles. The 
appearance of spurious alleles was random and they were 
only observed within a single sample tube and did not re-
peat in a control. Our data thus supports the assertion by 
Gill et al (7) that non-repeating peaks in the negative con-
trols do not affect their corresponding samples, as they are 
likely to have originated from a single molecule, which, by 
definition, can only exist in a single tube. Yet, to account 
for the randomness of drop-ins, more controls are required 
and should be amplified in triplicate along with case sam-
ples to determine whether drop-ins are reproducible, in-
dicating global contamination. These negative controls 
should also be injected at the same or more sensitive in-
jection parameters than their associated case samples.
An approximate 1:3 ratio was maintained between the 
samples and the negative control replicates, considering 
the extraction, additional purification, and amplification 
controls, all of which were amplified in triplicate. A sam-
ple batch fails if one of the negative control sets displays 
more than 2 repeated alleles. In the event of only 1 or 2 
repeated peaks in the negative control, the affected loci 
will be deemed inconclusive in the associated samples. 
As described in the results section, the validation showed 
that, even with protocols in place to minimize laboratory 
sources of drop-ins, we expect to observe some spurious 
alleles in our negative controls. Nevertheless, too many 
non-repeating peaks over 3 amplifications will also result 
in a failed batch, although these peaks may be isolated to 
that control tube and not indicate gross contamination.
Mixture assessment
If 3 confirmed alleles are present at only one locus in a sam-
ple where all other loci show 2 confirmed alleles at most, 
although this allele may be due to a second contributor to 
the sample, no conclusions can be drawn regarding the 
source of this extra allele. For example, the 1:50 and 1:49 
mixtures displayed only 2 loci with repeating minor peaks 
that were significantly shorter than the main peaks. The 
major component peaks behaved in the same manner as 
single-source samples. Therefore, samples with less than 3 
repeating peaks may be interpreted with the protocols for 
single-source samples with the following exception. Mix-
tures amplified from very small amounts of DNA, for exam-
ple <20 pg, as observed within the touched items study, 
may not contain sufficient DNA to generate repeating 
peaks, but there may be inconsistencies among the repli-
cates such that the possibility of a mixture should be con-
sidered. In these instances, the samples should be analyzed 
with mixture interpretation protocols as described below.
Stutter filters
The threshold where an analyst could remove stutter 
peaks from single-source samples, following locus-specif-
ic stutter filtering performed by the software, was set at 
20%. Although occasionally higher stutter was observed, 
this value was chosen to prevent the removal of real allele 
peaks. Manual stutter removal was not permitted for mixed 
samples. Interestingly, the overwhelming majority of non-
repeating foreign peaks observed in our samples were in 
the stutter position. There is the possibility that a non-re-
peating peak in the stutter position is both a drop-in peak 
and a stutter peak and that either one or both would not 
be detectable if they did not occur concurrently. Due to 
the low incidence of allelic drop-in observed in our nega-
tive controls and the expectation of a higher fidelity rate 
in samples rather than in negative controls, attributable to 
the competing template DNA, these peaks are likely stut-
ters. Nevertheless, to take a conservative approach, and 
since the level of peak imbalance precluded adjusting the 
stutter filters further, these concerns were addressed with 
the interpretation protocols as discussed below.
Heterozygote assignment for single-source samples
A locus was considered to be heterozygous based on 
the 2 highest repeating peaks in 2 amplifications. Due 
to the wide range of peak height differences, the as-
signment was not limited by an imbalance thresh-
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old with a few exceptions. To accommodate the range of 
stutter seen, if a repeating allele was in the plus or minus 
4 bp stutter position, and was less than 30% of the major 
peak height in 2 out of 3 amplifications, the possibility of 
a homozygote was considered, and a “Z” assigned to indi-
cate the possible presence of a second allele. The peak was 
considered a true heterozygote peak if the potential stut-
ter peak was larger than 50% of the main allele in the third 
amplification (Figure 8). Furthermore, if 2 repeating peaks 
were clearly major peaks, any additional minor repeating 
alleles were not considered in the profile. These peaks were 
often in the stutter position as observed in our evaluations 
of spurious alleles or could have been from a very minor 
contributor to the sample.
Homozygote assignment for single-source samples
Homozygote types have to be interpreted with cau-
tion to avoid assigning potential false homozygotes. 
As evidenced from the sensitivity studies, due to the en-
hanced peak heights resulting from high injection parame-
ters, peak height thresholds were not effective tools to dis-
cern true homozygote alleles. Rather, homozygotes were 
correctly assigned according to the following protocols 
based on peak height imbalance as well as the locus and 
quantity specific dropout rates presented previously. An al-
lele had to appear in all 3 amplifications to be considered 
a homozygote. The presence of an additional allele in one 
of the 3 amplifications can be indicative of allelic dropout 
in the other 2 replicates. However, if one peak was clearly 
the major peak and the minor peaks (even repeating minor 
peaks) were less than 30% of the major peak height in all 
3 amplifications, the allele was considered a true homozy-
gote. Alternatively, if the non-repeating minor drop-in was 
greater than 30% of the repeating peak, allelic drop out 
was suspected and the locus marked with a “Z”, to indicate 
the possible presence of a second allele (Figure 9).
Our validation demonstrated that the largest locus de-
tected in each color, particularly for samples amplified in 
the lower LT-DNA range, as well as THO1 and D16S539, of-
Figure 8.
Examples of repeating peaks in stutter position for single-source sam-
ples. This schematic shows 2 scenarios where a repeating peak is in the 
plus or minus four stutter position. The peak height ratio should be eval-
uated to determine the genotype. if the second repeating peak is less 
than 30% of the major peak in 2 out of 3 amplifications, the possibility of 
a homozygote should be considered and a “Z” assigned. if however, the 
second repeating peak is greater than 50% in one of the 3 amplifications, 
a heterozygote pair can be assigned.
Figure 9.
Example of replicate amplifications for potential false homozygotes. This 
schematic shows 3 scenarios of potentially homozygous loci. For sam-
ples amplified with more than 20 pg of dna, a homozygote type may 
be assigned to a single peak appearing in all replicates at a robust locus 
such as d21S11 above. in a case of drop-in, such as the example at an-
other robust locus, d7S820, a conservative approach is taken given that 
a second peak is greater than 30% of the height of the first. depicted in 
the third example, allelic dropout is always considered for all high mo-
lecular weight loci (CSF, d2S1338, d18S51, and FGa), as well as the loci 
identified as less efficient (d16S539 and THo1). in these cases a “Z” is as-
signed to indicate that a second allele may be present.
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ten appeared as false homozygote loci. To be more con-
servative, allelic dropout was therefore always considered 
for the last locus detected in each color and for THO1 and 
D16S539. In addition, due to the rate of dropout for sam-
ples with less than 20 pg, all apparently homozygous loci 
in samples amplified with this amount of DNA were as-
signed a “Z”. Care was also exercised if alleles in one of 3 
amplifications were completely different from those in the 
first 2 amplifications. In this case, the locus was deemed 
inconclusive.
Evaluation of mixed samples
For mixed samples, only clear major components can be 
interpreted unless 1 of the DNA sources is known, for ex-
ample an intimate sample. According to the mixture stud-
ies, mixtures with apparently equal ratios of contributors 
can only be used for direct comparison. Samples with vary-
ing ratios of contributors at several loci also may only be 
used for direct comparison. The number of contributors to 
a sample should also be considered for interpretation. A 
sample may have 3 or more contributors if 5 or more re-
peating alleles are present in at least 2 loci. If there is a clear 
major component, it may be possible to deduce the major 
contributor from a 3-person mixture. Often, this is not fea-
sible at all of the loci. For example, some degraded samples 
appear to be 3-person mixtures at the small loci, but the 
minor component(s) are not visible at the large loci.
Heterozygote assignment of major components in 
mixtures
In these studies, alleles were correctly assigned to a major 
component if they appeared in all 3 amplifications and if 
they were the major peaks in 2 of the 3 amplifications. A 
heterozygote pair for the major component was called if 2 
of the 3 amplifications showed a peak balance greater than 
or equal to 50% (Figure 10A). During the validation, exami-
nation of peak imbalance in single-source samples indicat-
ed that for more than 99% of the replicates and locations 
tested no more than 1 replicate for each locus showed 
peak imbalance greater than 50%. Therefore, if major peaks 
were within 50% of one another in at least 2 replicates, a 
heterozygote pair was likely, which proved to be empiri-
cally correct.
In order to ensure correct allelic pairing, care should be 
taken to not consider saturated peaks in ratio calculations. 
For degraded samples, high injection parameters may be 
required to detect long amplicons, whereas alleles at small 
loci may saturate the AB 3100 detector and are not suitable 
for ratio calculations. In these instances, one may combine 
injection results as long as data from overlapping loci are 
generated.
Regardless of the peak balance, if it was not apparent that 
a sample had a ratio of at least 1:3, then all loci that con-
tained only 2 alleles were considered possible mixed 
loci. This was particularly relevant for the less robust 
loci and TPOX, a locus prone to primer binding site 
Figure 10.
deduction of major components of mixed samples. This schematic 
shows scenarios for assignment of major component genotypes. (A) al-
leles can be assigned to a major component if they appear in all 3 am-
plifications, are the major peaks in 2 out of the 3, and the pair shows a 
peak balance ≥0.5. (B) illustration of the possibility of a true homozygote 
if all additional peaks are less than 30% of the main peak and the locus 
is robust. However, for non-robust-loci, the possibility of a false homozy-
gote must be considered and a “Z” is assigned. in the above examples, all 
peaks are within 50% of each other unless otherwise indicated. Striped 
peaks represent minor component alleles.
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mutations (32) and applicable to mixtures containing a ho-
mozygote and a heterozygote which share the same allele. 
Note also that the contribution of the minor component 
to a peak shared with the major component is not sub-
tracted prior to calculating the peak imbalance. Therefore, 
in a mixed sample, the peak imbalance may seem exag-
gerated, but this serves to ensure a more conservative ap-
proach.
Homozygote assignment of major component in 
mixtures
As evidenced in these studies, homozygote genotypes 
had to be deduced carefully. If 1 peak was clearly the major 
peak and the minor peaks (even if they repeated) were less 
than 30% of the major peak in all 3 amplifications, an al-
lele was assigned as a true homozygote. In between cases, 
where the height of the second allele was between 30% 
and 50% of the height of the main peak, it was not clear 
whether the major contributor was heterozygous or ho-
mozygous. In this case, a major peak was assigned to the 
major component along with a “Z” (Figure 10B).
Based on validation data, as for single-source samples, if 
only one peak could be called, allelic dropout and a “Z” 
were considered for the high molecular weight or less effi-
cient loci. This therefore affected CSF1PO, THO1, D16S539, 
D2S1338, D18S51, and FGA or the last evident locus of a 
particular color in 2 of 3 amplifications in a degraded sam-
ple. Additionally, a “Z” was always assigned at TPOX for the 
reason discussed above. As with single-source samples, 
for amplifications with less than 20 pg, all potential homo-
zygotes at all loci were considered false and a “Z” was as-
signed.
Figure 11.
High sensitivity interpretation decision points. This flowchart summarizes the low template dna interpretation process.
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additional mixture interpretation issues
When alleles could not be assigned to the major compo-
nent, the locus was not deduced and was deemed incon-
clusive. Minor components could not be reliably deter-
mined. The degree of allelic sharing within a mixture was 
not readily evident as replicate amplifications displayed 
shifts in ratios between various mixture alleles within the 
same locus. Nevertheless, minor peaks may be used for 
comparison. From our mixture studies, 98.9% of the non-
repeating peaks were either attributable to the major or 
the minor components or were in stutter position and 
thus were likely not due to random events. However, for 
extreme mixtures often very few minor alleles are detect-
ed, and these samples may not be suitable for comparison 
to the minor component.
All mixtures, as well as single-source interpretation deci-
sion points and guidelines, were summarized in a flow-
chart (Figure 11). In addition to applying these protocols 
to the replicates, the pooled sample should be considered. 
Although the pooled sample is not evaluated indepen-
dently, if it does not confirm the allelic assignments from 
the replicates, caution should be exercised.
Profile comparison and statistical evaluation
For the purposes of statistical evaluation for single-source 
or deduced major component profiles when calculating 
the random match probability, only the assigned alleles 
that meet the interpretation requirements should be used. 
For loci assigned a “Z,” only one allele is considered and the 
random match probability is calculated as 2p. For mixtures 
where the profile of the major component cannot be de-
termined, a known sample may be compared and quali-
tative conclusions can be drawn. If the known sample’s 
alleles are labeled at all loci where DNA alleles are repeat-
ing, the probability of exclusion of the individual from the 
mixture may be calculated using the Random Man Not Ex-
cluded method.
Since allelic dropout caused by stochastic effects is a com-
mon occurrence for LT-DNA samples, the absence of a 
comparison sample’s alleles from a mixture is not neces-
sarily indicative of an exclusion. An analyst should consider 
whether the alleles detected are what one would expect 
to see had an individual contributed to the mixture. The 
amount of DNA amplified, the number of contributors to 
the mixture, the empirically defined loci characteristics, 
and the length of the repeats should be evaluated. The 
phenomena of allelic drop-in and dropout must be taken 
into account when evaluating the weight of the missing 
allele(s). Statistical methods to achieve this purpose are 
in the process of being refined and validated for forensic 
casework (33,34). In the absence of such validated statisti-
cal methods, qualitative results may still be provided. Once 
likelihood ratio methods are validated, they could also be 
applied to the scenarios described above.
ConCluSion
Through extensive testing of low template single-source 
and mixed samples, we have developed quality control, 
testing, and interpretation protocols. These protocols were 
designed to address the concerns regarding the increased 
sensitivity of this system and the accompanying stochas-
tic effects (20). Although not every situation can be antici-
pated, employing these conservative interpretation proto-
cols and evaluating the sample as a whole including the 
pooled injection ensures that allelic assignments, when 
they can be made, are correct.
The detection of an individual’s alleles in an evidence pro-
file, whether it be from skin cells recovered from an item or 
from a blood, saliva, or semen stain, simply indicates that 
their DNA may be present. No inferences about the means 
of deposition should or can be made. Conversely, in the 
case of handled items, the absence of an individual’s alleles 
does not indicate that this individual did not touch the ob-
ject; rather the DNA might not have been detectable. Very 
partial profiles must be interpreted carefully and they may 
not be suitable for comparison. The weight of the evidence 
and the absence or presence of DNA is dependent upon 
the context of the case. It is for the finders of fact to assign 
the significance of these results.
These concerns do not impact the reliability of high sen-
sitivity DNA testing and the interpretation protocols de-
scribed in this paper. Our studies demonstrated that these 
methodologies generated robust and reliable results 
which may prove valuable depending upon the context of 
the case. Therefore, implementation of these methods, or 
others suitably verified, in conjunction with an appropriate 
quality control program, ensures that LT-DNA testing is fit 
for forensic purposes.
acknowledgments
The authors would like to thank Adele Mitchell for re-
viewing the manuscript.
FORENSIC SCIENCE266 Croat Med J. 2009; 50: 250-67
www.cmj.hr
References
1 Wickenheiser Ra, Roney JM, Hummel KHJ, Szakacs na, MacMillan 
CE, Kuperus WR. unusual exhibit material yielding successful dna 
profiles using PCR STR typing. in: Proceedings of the 11th annual 
Symposium on Human identification; 1999 Sep 29-oct 3; lake 
Buena Vista, Fl, uSa. Madison (Wi): Promega Corporation; 1999.
2 Hummel KHJ, Wickenheiser Ra, Roney JM, Szakacs na, MacMillan 
CE, Kuperus WR. update on unusual exhibit material yielding 
successful dna profiles using PCR STR typing. in: Proceedings 
of the 4th annual Cambridge Health institute’s dna Forensics 
Conference; 2000 May 31-Jun 2; Springfield, Va, uSa. Madison (Wi): 
Promega Corporation; 2000.
3 Szakacs na, MacMillan CE, Roney JM, Wickenheiser Ra, Hummel 
KHJ, Kuperus WR. Perspectives on dna casework: unusual exhibits, 
mixture interpretation, and profiles from inhibited PCR reactions. 
in: Proceedings of the 11th annual Symposium on Human 
identification; 2000 oct 10-13, Biloxi, Mi, uSa. Madison (Wi): 
Promega Corporation; 2000.
4 Wickenheiser Ra. Trace dna: a review, discussion of theory, and 
application of the transfer of trace quantities of dna through skin 
contact. J Forensic Sci. 2002;47:442-50. Medline:12051321
5 Gill P. application of low copy number dna profiling. Croat Med J. 
2001;42:229-32. Medline:11387628
6 Sewell J, Quinones i, ames C, Multaney B, Curtis S, Seeboruth H, 
et al. Recovery of dna and fingerprints from touched documents. 
Forensic Sci int; Genet. 2008;2:281-5. Medline:19083837 
doi:10.1016/j.fsigen.2008.03.006
7 Gill P, Whitaker J, Flaxman C, Brown n, Buckleton J. an investigation 
of the rigor of interpretation rules for STRs derived from less than 
100 pg of dna. Forensic Sci int. 2000;112:17-40. Medline:10882828 
doi:10.1016/S0379-0738(00)00158-4
8 Kloosterman ad, Kersbergen P. Efficacy and limits of genotyping 
low copy number (lCn) dna samples by multiplex PCR of STR loci. 
J Soc Biol. 2003;197:351-9. Medline:15005516
9 Staiti n, Giuffre G, di Martino d, Simone a, Sippelli G. Tuccari G, et 
al. Molecular analysis of genomic low copy number dna extracted 
from laser-microdissected cells. int Congr Ser. 2006;1288:568-70. 
doi:10.1016/j.ics.2005.11.126
10 anjos MJ, andrade l, Carvalho M, lopes V, Serra a, oliveira C, et al. 
low copy number: interpretation of evidence results. int Congr Ser. 
2006;1288:616-8. doi:10.1016/j.ics.2005.09.118
11 Roeder ad, Elsmore P, Greenhalgh M, Mcdonald a. Maximizing 
dna profiling success from sub-optimal quantities of dna: 
a staged approach. Forensic Sci int; Genet. 2009;3:128-37. 
Medline:19215883 doi:10.1016/j.fsigen.2008.12.004
12 Findlay i, Taylor a, Quirke P, Frazier R, urquhart a. dna 
fingerprinting from single cells. nature. 1997;389:555-6. 
Medline:9335493 doi:10.1038/39225
13 applied Biosystems, Human identification department. 
ampFSTR® identifiler™ PCR amplification kit user’s manual. Foster 
City (Ca): applied Biosystems; 2001.
14 Bajda E, Shaler R, Prinz M, Caragine T. Modification of amplification 
and STR conditions to enhance sensitivity of the identifiler® 
(aB) and PowerPlex® 16 (Promega) kits for low copy number 
dna samples. in: Proceedings of the 15th annual international 
Symposium on Human identification; 2004 oct 4-7; Phoenix, aZ, 
uSa. Madison (Wi): Promega Corporation; 2004.
15 Smith PJ, Ballantyne J. Simplified low-copy-number dna 
analysis by post-PCR purification. J Forensic Sci. 2007;52:820-9. 
Medline:17553095 doi:10.1111/j.1556-4029.2007.00470.x
16 Forster l, Thomson J, Kutranov S. direct comparison of post-28-
cycle PCR purification and modified capillary electrophoresis 
methods with the 34-cycle “low copy number” (lCn) method for 
analysis of trace forensic dna samples. Forensic Sci int; Genet. 
2008;2:318-28. Medline:19083842 doi:10.1016/j.fsigen.2008.04.005
17 Strom CM, Rechitsky S. use of nested PCR to identify charred 
human remains and minute amounts of blood. J Forensic Sci. 
1998;43:696-700. Medline:9608708
18 Hanson EK, Ballantyne J. Whole genome amplification strategy 
for forensic genetic analysis using single or few cell equivalents of 
genomic dna. anal Biochem. 2005;346:246-57. Medline:16212929 
doi:10.1016/j.ab.2005.08.017
19 Whitaker JP, Cotton Ea, Gill P. a comparison of the characteristics of 
profiles produced with the aMPFlSTR SGM Plus multiplex system 
for both standard and low copy number (lCn) STR dna analysis. 
Forensic Sci int. 2001;123:215-23. Medline:11728750 doi:10.1016/
S0379-0738(01)00557-6
20 Budlowle B, Hobson d, Smerick J, Smith J. low copy number-
consideration and caution. in: Twelth international Symposium on 
Human identification; 2001 oct 9-12, Biloxi, Mi, uSa. Madison (Wi): 
Promega Corporation; 2001.
21 davis JM, editor. Basic cell culture: a practical approach. oxford 
(uK): oxford university Press; 1994.
22 Kwok S, Higuchi R. avoiding false positives with PCR. nature. 
1989;339:237-8. Medline:2716852 doi:10.1038/339237a0
23 Tamariz J, Voynarovska K, Prinz M, Caragine T. The application of 
ultraviolet irradiation to exogenous sources of dna in plasticware 
and water for the amplification of low copy number dna. J 
Forensic Sci. 2006;51:790-4. Medline:16882220 doi:10.1111/j.1556-
4029.2006.00172.x
24 Shaw K, Sesardic i, Bristol n, ames C, dagnall K, Ellis C, et 
al. Comparison of the effects of sterilisation techniques on 
subsequent dna profiling. int J legal Med. 2008;122:29-33. 
Medline:17318649 doi:10.1007/s00414-007-0159-5
25 Stratalinker® uV Crosslinker instruction Manual, Model 2400 
Catalog #400075 (120 V), #400076 (230 V) and #400676 (100 
V). Revision #122003 in #70034-06. la Jolla (Ca): Stratagene 
Copyright; 2002. 
26 Schiffner la, Bajda EJ, Prinz M, Sebestyen J, Shaler R, Caragine 
267Caragine et al: Low Template Testing and Interpretation
www.cmj.hr
Ta. optimization of a simple, automatable extraction method 
to recover sufficient dna from low copy number dna samples 
for generation of short tandem repeat profiles. Croat Med J. 
2005;46:578-86. Medline:16100760
27 Walsh PS, Metzger da, Higuchi R. Chelex 100 as a medium for 
simple extraction of dna for PCR-based typing from forensic 
material. Biotechniques. 1991;10:506-13. Medline:1867860
28 nicklas Ja, Buel E. development of an alu-based, real-time PCR 
method for quantitation of human dna in forensic samples. J 
Forensic Sci. 2003;48:936-44. Medline:14535658
29 Caragine T, Bajda E, Sebestyen J, Tamariz J, Prinz M. a High 
Sensitivity dna testing methodology. problems and proposed 
solutions. in: The 4th European-american School in Forensic 
Genetics and Mayo Clinic Course in advanced Molecular and 
Cellular Medicine, 2005; dubrovnik, Croatia. Zagreb: Exto 
Produkcija; 2005.
30 Prinz M, Schiffner l, Sebestyen Ja, Bajda E, Tamariz J, Shaler RC, et 
al. Maximization of STR dna typing success for touched objects. 
int Congr Ser. 2006;1288:651-3. doi:10.1016/j.ics.2005.10.051
31 dixon la, dobbins aE, Pulker HK, Butler JM, Vallone PM, Coble 
Md, et al. analysis of artificially degraded dna using STRs and 
SnPs – results of a collaborative European (EdnaP) exercise. 
Forensic Sci int. 2006;164:33-44. Medline:16343834 doi:10.1016/
j.forsciint.2005.11.011
32 Kline MC, Jenkins B, Rodgers S. non amplification of a vWa allele. J 
Forensic Sci. 1998;43:250.
33 Gill P, Kirkham a, Curran J. loComation: a software tool for 
the analysis of low copy number dna profiles. Forensic 
Sci int. 2007;166:128-38. Medline:16759831 doi:10.1016/
j.forsciint.2006.04.016
34 Gill P, Curran J, neumann C, Kirkham a, Clayton T, Whitaker J, et al. 
interpretation of complex dna profiles using empirical models 
and a method to measure their robustness. Forensic Sci int; Genet. 
2008;2:91-103. Medline:19083804 doi:10.1016/j.fsigen.2007.10.160
